Latest chemotherapy Stories
Proof-of-Concept Trial Targets DNA Repair in Bile Duct Cancers SAN DIEGO and NEW TAIPEI CITY, Taiwan, June 17, 2014 /PRNewswire-iReach/ -- Senhwa Biosciences, Inc.
CAMBRIDGE, Mass., June 16, 2014 /PRNewswire/ -- Boston Biomedical, a company focused on the research and development of novel cancer therapeutics targeting cancer stem cells (CSC), today provided
Health Canada has reinstated Biolyse Pharma’s Establishment Licence (EL) after sending in a team of inspectors to look at manufacturing within the St.Catharines based Pharmaceutical.
SCHAUMBURG, Ill., June 10, 2014 /PRNewswire-USNewswire/ -- Extensive clinical experience suggests that hyperthermic intraperitoneal chemotherapy (HIPEC) may play an important role in the ongoing
New Research Finds Patient Shift from Physicians' Community Cancer Clinics to Hospitals Increases Cost of Cancer Care WASHINGTON, June 10, 2014 /PRNewswire/ -- The Berkeley Research Group (BRG)
TSX Venture: QPT EDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc.
KRS Global Biotechnology (KRS-GBT), premier compounding pharmacy and FDA registered human drug compounding outsourcing facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C
The makers of an experimental mesothelioma drug say it may help prevent mesothelioma relapse after chemotherapy. (PRWEB) June 05, 2014 Veratem, Inc.,
The Venezuelan model and soap opera actress Sheyene Gerardi was diagnosed with stage 4 lymphoma and given only 3 months to live.
Sister of Late L.A.
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.